Notably, SM demonstrated considerable inhibitory activity against AChE, highlighting its potential for cholinergic enhancement, which is a crucial focus in the treatment of Alzheimer’s disease. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.